SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-20-000103
Filing Date
2020-02-06
Accepted
2020-02-06 17:24:35
Documents
40
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e1699_10q.htm 10-Q 446297
2 EXHIBIT 10.1 e1699_10-1.htm EX-10.1 17213
3 EXHIBIT 31.1 e1699_31-1.htm EX-31.1 5409
4 EXHIBIT 31.2 e1699_31-2.htm EX-31.2 5703
5 EXHIBIT 32.1 e1699_32-1.htm EX-32.1 4540
6 GRAPHIC image_001.jpg GRAPHIC 115293
7 GRAPHIC image_002.jpg GRAPHIC 78181
  Complete submission text file 0001731122-20-000103.txt   2037484

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE avxl-20191231.xml EX-101.INS 233284
9 XBRL SCHEMA FILE avxl-20191231.xsd EX-101.SCH 23003
10 XBRL CALCULATION FILE avxl-20191231_cal.xml EX-101.CAL 23093
11 XBRL DEFINITION FILE avxl-20191231_def.xml EX-101.DEF 72355
12 XBRL LABEL FILE avxl-20191231_lab.xml EX-101.LAB 176169
13 XBRL PRESENTATION FILE avxl-20191231_pre.xml EX-101.PRE 122302
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 20583700
SIC: 8731 Services-Commercial Physical & Biological Research